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Abstract The efficient induction of embryonic stem cells
into hematopoietic stem cells (HSCs) requires understanding
the pro or inhibitory regulatory networks, which are involved
in these pathways. Transforming growth factor b family is a
super family of growth factors such as TGF-b1, TGF-b2,
TGF-b3, and some other cytokines. Previous works indicate
that some of TGF-b subfamilies have negative regulatory
effect during hematopoietic differentiation and HSC prolif-
eration. The inhibitory effects of TGF-b1 in early stage of
differentiation of endothelial and hematopoietic cells have
been shown. Therefore, in the present study, in order to
evaluate the promotion of hematopoietic differentiation, the
activities of TGF-b regulatory factor were reduced through
knockdown of TGF-bR2 expression. The ESCs were trans-
duced by Lentivirus carrying SiTGF-bR2 and its scramble
separately. Green fluorescent protein (GFP) was used as a
marker to monitor gene expression. Six days post transduc-
tionGFP? colonieswere used for EB generation and the next
day, the same size EBs were transferred in differentiation
media involved in defining cytokines. The expression level
of hematopoietic-specific genes was evaluated in 0, 7, and
15-days of differentiation. The real-time PCR analysis in
15 day EBs showed 2–3-folds increase in SiTGF-bR2 as
compared with the scramble. Therefore, this finding may be
confirmed if TGF receptor silencing can reduce the
inhibitory effect of TGF-b during early hematopoietic
differentiation.
Keywords ESCs  HSCs  TGF-bR2 signaling
Introduction
Today, transplantation of hematopoietic stem cells (HSCs)
to develop multi lineage hematopoietic cell engraftment is
themost common clinical cell-based therapy. Currently bone
marrow, umbilical cord blood, and mobilized peripheral
blood are the major sources of transplantable HSCs. The
limited cell dose, the lack of additional immune cells if donor
lymphocytes are needed and resultant delayed engraftment
are some disadvantages of HSC transplantation [1]. To
overcome these problems researchers need an appropriate
alternative for generation of hematopoietic cells [2].
Embryonic stem cells (ESCs) are pluripotent cells
established from the inner cell mass of blastocyst-stage
embryos, in both mouse and human beings [3]. They can be
differentiated into any of the cell types in three-germ layers
[4, 5]. These characteristics make ESC attractive as the cell
source for generation of hematopoietic cell. There are nu-
merous reports on the production of HSCs or hematopoietic
progenitors cells (HPCs) from ESCs or induced pluripotent
stem cells (iPSCs). The human ES cell (hESC) differ-
entiation system provides an outstanding alternative to the
early embryo for identification of the hemangioblast as it
allows easy access to large number of cells representing the
earliest stages of hematopoietic commitment [6].
There are two major approaches in differentiation of
ESC to HSC. First being non-genetic approach which is
focused on mimicking the hematopoietic niche; second
related to manipulation of the expression of genes
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responsible for hematopoietic development [7]. To achieve
this goal different techniques have been applied, including
the use of feeder layers [8], embryoid body (EB) formation
[9], cytokine cocktails, and a combination of these tech-
niques [8, 9]. Although it has been proved particularly
difficult to produce the most potent HSCs capable of long-
term repopulating HSCs (LTR-HSCs) that can reconstitute
bone marrow and generate fully mature and functional cells
[10]. So, identification of genes and key signaling pathways
that regulate the hematopoietic development of ESC have
been extensively studied over the past decade to determine
optimal conditions for in vitro expansion of HSCs in
the hope of increasing the number of engraftable LTR-
HSCs.
The transforming growth factor b (TGF-b) family is a
super-family of growth factors such as TGF-b1, TGF-b2,
TGF-b3, and some other cytokines [11]. These mem-
bers bind to receptor complexes composed by TGFb re-
ceptor type I, activating receptor I, and receptors type II
(TGFbRII, BMP-R II, and activin-RII), also called activin-
like kinase receptor (Alk) [12]. It is well-known that TGF-
b exerts multiple biological effects in regulating a wide
variety of biological processes, namely: cell growth,
apoptosis, differentiation, migration, extracellular matrix
(ECM) production, immunity, angiogenesis, tumor metas-
tasis, invasion, and embryonic development [13]. TGF-b
also is a regulator of all stages of hematopoiesis [14] which
shows pro- or anti-effect during differentiation stage. Pre-
vious works indicate that TGF-b1, one of subfamilies, has
inhibitory effect in early stage of differentiation of en-
dothelial and hematopoietic cells which are derived from a
common precursor [12, 15]. Some reports demonstrated
that TGF-b inhibition could maintain the proliferation and
vascular identity of purified endothelial cells derived from
hESCs. Further studies are needed to investigate how TGF-
b regulates hematopoietic cell differentiation.
In the present study TGF-bR2, as one of the important
receptor of TGF-b subunits was knocked down via Smad
pathway. According to the different origins of the yolk sac
as well as hemangiogenic lineages in mouse and human
beings, the effect of TGF-b in these two species is not the
same. Therefore, to examine the role of TGF-b in early
human hematopoietic differentiation, it is necessary to use
human embryonic stem cell-derived EB to recapitulate
early stages of embryonic development [15]. To achieve
this aim hematopoietic progenitors that were generated
from EBs in transduced siTGF-bR2 and scramble groups
were explored and compared with EBs in another group,
with combination of defined cytokines. The authors at-
tempted to determine whether TGF-b signaling inhibition
could promote hematopoietic differentiation on early stage
of differentiation in hEB-derived cells or not.
Material and Methods
Human ESCs Culture
The hESC line used in the present study, H6 (NIH code
WA01) was obtained from Royan Research Institute. It is
maintained on mitomycine inactivated mouse embryonic
feeder cells in stem cells media. This media consists of
DMEM/F12 (50:50, Invitrogen) supplemented with 20 %
knockout serum replacement (SR, Gibco), 100 M
nonessential amino acids (Gibco, 11140), 2 mM glutamine
(Invitrogen, 35050), 50 U/mL penicillin, 50 g/mL strepto-
mycin (Invitrogen, Grand Island, NY), 10-4 M b-mercap-
toethanol (Sigma, St Louis, MO), and 20 ng/mL hbFGF
(PeproTech, RockyHill, NJ, USA, 100-18B) in 25T cell
culture flask Techno Plastic Products (TPP, 93100). When
ESC colonies reached to 70–80 % confluency they were
passaged enzymatically using a 1 mg/mL solution of col-
lagenase type-IV (Gibco, 17104-019) for 3 min and the
small clumps of ESC colonies were centrifuged at
1200 rpm for 5 min and transferred on to fresh feeder in a
new flask.
hEB Generation
To generate EBs, H6 colonies were dissociated to small
clusters (*10–20 cells) using collagenase IV (1 mg/mL)
for 5 min followed by Trypsin–EDTA 0.05 % solution
(Sigma, T4799) for approximately 2 min and were cen-
trifuged at 1200 rpm for 5 min. The clusters were plated in
6-well non-treated-plate (JET BIOFIL) in 2 mL aggre-
gation media, consisting of Iscove’s Modified Dulbecco’s
Medium (IMDM, Invitrogen, Grand Island, NY) supple-
mented with 20 % fetal bovine serum (FBS), 100 M non-
essential amino acids, 2 mM glutamine, 50 U/mL peni-
cillin, 50 g/mL streptomycin, 10-4 M b-mercaptoethanol,
10 ng/mL BMP-4 (PeproTech, RockyHill, NJ, USA), and
50 g/mL ascorbic acid (Sigma). The aggregates were in-
cubated at 37 C in 5 % CO2 atmosphere. Twenty-four
hours later EB formation was checked by an invert mi-
croscope (Nikon, Eclipse TS100).
EB Harvest and Dedifferentiation
The next day after EB formation, same size EBs were
harvested and replaced by the same medium supplemented
with a cocktail of cytokines consisting of 100 ng/mL hu-
man stem cell factor (hSCF), 100 ng/mL human Flt3-li-
gand (hFlt3), 100 ng/mL of TPO, 10 ng/mL human
Interleukin-3 (hIL-3), 10 ng/mL human Interleukin-6 (hIl-
6), 50 ng/mL human granulocyte colony stimulating factor
(hG-CSF), 10 ng/mL human bone morphogenetic protein-4
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(hBMP4) (all of them from PeproTech, RockyHill, NJ,
USA). The culture medium was changed every 3 days until
day 15th for hEBs differentiation.
Human Umbilical Cord Blood (UCB) Purification
The UCB was transported to the laboratory by 150 mL
transfer bags (Baxter, R4R2001). Then, 6 % Hetastarch in
0.9 % Sodium Chloride was added to the UCB at a con-
centration of 20 % blood volume in 50 mL centrifuge tube
(TPP) and was kept for 2 h in laminar hood. The super-
natant containing the desired nucleated cells was expressed
off into a second falcon and after that, it was centrifuged at
1500 rpm for 5 min. The supernatant was added slowly to
3 mL Ficoll (Sigma-Aldrich, Steinbach, Germany) and
was centrifuged at 1800 rpm for 20 min in 25 C. Then,
UCB mononuclear cells (MNCs) from the interface were
collected and washed twice in phosphate-buffered saline
(PBS) and centrifuged at 1200 rpm for 5 min in 25 C
again. The supernatant was discarded and the MNCs were
suspended in 5 mL RPMI containing 10 % FBS, then they
were transferred to 25T flask. After 5 days, single cells
were ready for the first passage [16].
Vector Construction and Lentivirus Production
Both piLenti-siTGF-bR2-GFP (i024469a) and Scrambled
siRNA GFP lentiviral vector (LV015-G) were purchased
from Applied Biosystems. After that, plasmids were
propagated and purified using a QIAfilter Plasmid Maxi Kit
(Qiagen, Germany).
Lentiviruses were produced by co-transfecting of HEK-
293T cells with two plasmids separately viz. gag-pol ex-
pression plasmid, psPAX and VSV-G envelop plasmid.
The pMDG.2 based on the calcium phosphate precipitation
principle [12, 13]. Briefly, twenty-four hours prior to
transfection, 4 9 106 HEK-293T cells were plated on
10 cm2 plates [Techno Plastic Products (TPP), 93100] and
incubated in humidified atmosphere at 37 C, 5 % CO2
overnight to reach 70–80 % confluence. The media was
Dulbecco’s Modified Eagle Medium (DMEM) a high
glucose supplemented with 10 % FBS without antibiotics.
Two hours prior to transfection, the medium was replaced
with fresh medium without FBS and then co-transfected
with 22.5 lg of eGFP-plasmid containing desired gene,
14.6 lg of psPAX, 7.9 lg of pMDG.2, 50 lL CaCl2
2.5 mM. Then, 450 lL of 29 HBS (140 mM NaCl,
1.5 mM Na2HPO4, 50 mM HEPES, pH = 7.05) was added
and mixed gently and then incubated at room temperature
(RT) for 20 min according to Trono’s Lab instruction. The
mixture was added drop-wise onto the HEK-293T cells.
Before returning to the incubator, the plates were rocked
back and forth and then sideways to achieve a uniform
distribution of the precipitates throughout the plate. Sixteen
hours later, the cells were washed once with DMEM and
fresh medium containing 10 % FBS was added. The su-
pernatant containing Lentiviruses was harvested 48–72 h
post-transfection and was centrifuged to remove cell de-
bris. Then it was filtered passing through 0.45 lm PVDF
Durapore filter (Millipore, Bedford, MA). Viral super-
natants were concentrated by ultracentrifugation at
50,0009g for 2 h in a SW-28 rotor (Beckman, Palo Alto,
CA). The virus pellets were resuspended in the medium
that was used to produce them. To estimate vector particles
(p24) the enzyme-linked immunosorbent assay (ELISA) kit
(DIA.PRO. Italy) was used. Virus titer was determined by
fluorescence-activated cell sorting analysis of GFP positive
HEK-293T cells and was approximately 2 9 109 trans-
ducing units (TU)/mL medium [17, 18].
Transduction of hESCs
At the day of transduction (day 0), H6 hESCs were washed
with PBS and dissociated with 1 mg/mL collagenase type
IV for 3 min and centrifuge at 1200 rpm for 5 min, then
the supernatant was discarded. Dissociated cells and viral
particles in mouse embryonic fibroblast-condition medium
(MEF-CM) were transferred and incubated 2 h at 37 C in
CO2 incubator, then all clumps were plated on mitomycin-
C inactivated MEF feeder cells. Next day (day 1) medium
was discarded and fresh viruses were added to H6 cells on
MEF feeder with the same procedure. Six days after
transduction GFP-positive colonies were picked up me-
chanically under fluorescence microscope (Nikon Multi-
zoom AZ100 Multi-Purpose) for subsequent EB formation
and molecular evaluation. ESCs were transduced with
Lentivirus containing siTGF-bR2 and Scramble separately
in two groups, as shown in Fig. 1.
Real-Time Polymerase Chain Reaction
Total RNA of EBs in all groups was extracted using
BIOZOL Kit (BSC51M1) according to the manufacturer’s
instructions. The total extracted RNA was measured by
NanoDrop ND-1000 (Peqlab, Erlangen, Germany). The
cDNA was synthesized from 1 lg of total RNA using the
PrimeScriptTM RT reagent Kit (Takara Bio Inc, RR037A)
at 37 C for 15 min for the reverse transcription, 85 C for
5 s to inactivate the reverse transcriptase (RT enzyme).
The sequence of oligonucleotide primers used in this
study for gene amplification were obtained from previous
published articles [7, 19–21] and some of them were de-
signed using Perl Primer software (version 2.0.0.7). The
sequences are shown in Table 1.
Relative transcript expression levels of all groups were
measured by quantitative real-time PCR (Q-RT-PCR)
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using a SYBR Green master mix (Roche Applied Science,
Indianapolis, IN, USA) based on method described by
manufactures. The real-time PCR performed in 10 lL re-
action contained: 5 lL of SYBR Green master mix, a 2.5
nM concentration of each forward and reverse primer, and
60 ng/lL of cDNA sample. Then, all micro-tubes were
placed into Rotor-Gene 3000 (Corbett, Australia). The re-
action protocol was as follows: an initial denaturation step
at 95 C for 10 min, followed by 40 cycles of 95 C for
10 s (denaturation), 58–66 C for 20 s (annealing), and
72 C for 20 s (extension). Standard curves were generated
and the mean threshold cycle (CT) values of each dilution
in triplicate, and mean CT values of samples in duplicate
were used for quantity calculation. The averages of fold
change were calculated by differences in CT between
samples and GAPDH gene (internal control). The relative
quantification in gene expression was determined using the
2-DDCt method. GAPDH was used as an internal control to
normalize and a melting curve was acquired by heating the
product to 95 C, cooling to 55 C and maintaining at
70 C. The expression levels of hematopoietic progenitor
specific transcripts (c, e-globin, and Brachyury), matura-
tion markers (CD34, a, and b-globin) and stem cells
specific transcripts POU5F1 (OCT4) were analyzed in the
present study.
Statistical Analysis
The variance between groups was calculated by T test. The
data were collected in Statistics programs for the Social
Sciences software, (SPSS, Inc., Chicago, IL, USA) version
20. In the present study p value of B0.05 was considered
statistically significant.
Fig. 1 The project plan of the study
Table 1 The sequence of primers used for gene amplification
Primer names Sequence Product length (bp) Accession number Reference
OCT4-F 50-ACATCGCCAATCAGCTTGG-30 51 NM_001285987 Ratajczak et al. [19]
OCT4-R 50-AGAACCATACTCGAACCACAT-30
TGF-bR2-F 50-TTTTCCACCTGTGACAACCA-30 342 NM_003242 Designed
TGF-bR2-R 50-GCTGATGCCTGTCACTTGAA-30
Brachuary-F 50-CCTCGAATCCACATAGTGAGAG-30 117 NM_001270484 Designed
Brachuary-R 50-AAGAGCTGTGATCTCCTCGT-30
CD34-F 50-ACATCACAGAAACGACAGTC-30 143 NM_001773 Designed
CD34-R 50-TGTCTCTGGAGTTGAAACGT-30
GATA1-F 50-CACTCCCCAGTCTTTCAG-30 199 NM_002049 Designed
GATA1-R 50-TCAAAGTCTCCAGGAAGC-30
a9-globin-F 50-ACTCTTCTGGTCCCCACAG-30 153 NM_000517 Ledran et al. [7]
a9-globin-R 50-GTGGGGAAGGACAGGAAC-30
b-globin-F 50-GCAACCTCAAACAGACACCA-30 198 NM_000519 Ledran et al. [7]
b-globin-R 50-TTAGGGTTGCCCATAACAGC-30
e-globin-F 50-ATATCTGCTTCCGACACAGC-30 303 NM_005330 Ledran et al. [7]
e-globin-R 50-GCTTGAGGTTGTCCATGTTT-30
c-globin-F 50-CACAGAGGAGGACAAGGCTA-30 238 NM_000184 Ledran et al. [7]
c-globin-R 50-CTTGAGATCATCCAGGTGCT-30
GAPDH-F 50-CTCATTTCCTGGTATGACAACGA-30 121 NM_001256799 Pakzad et al. [20]
GAPDH-R 50-TTCCTCTTGTGCTCTTGCTG-30
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Results and Discussion
Virus Production Carrying siTGF-bR2
and Scramble
HEK-293T cells were transfected with a lentiviral plasmid
expressing siTGF-bR2 and scramble separately by CaPO4
precipitation method. In the present study 90 % efficiency
in transfection were observed (Fig. 2A, B). To evaluate the
optimal efficiency of Lentiviruses in transduction, con-
centrated lentiviral vectors at a multiplicity of infection
(MOI) of 10 were used for transduction of human dermal
fibroblasts (HDFs). After 72 h the results show high effi-
ciency of eGFP expressing in transduced HDFs (Fig. 2C).
The confirmed viruses were used for ESCs transduction
according to the plane that is shown in Fig. 1.
EB Formation and Differentiation of HSC-Like
Precursor In Vitro
Undifferentiated ESCs were infected with lentiviral ex-
pression vectors carrying siTGF-bR2 and its scramble
separately. To follow the expression of siTGF-bR2 in vitro,
the co-expression system based on co-translational
separation of eGFP was used. Transduction was performed
three times on each group with MOI 10. After 6 days,
eGFP? colonies were scraped and dissected into small
clusters under fluorescence microscope. As mentioned, in
the present study during EB formation induction method
was used for the differentiation of stem cells into the HSCs
(Fig. 3). To promote hematopoiesis, the undifferentiated
H6 cell clusters (transduced and non-transduced) were
transferred to the EB media in three groups of siTGF-bR2,
scrambled and non-transduced group. Twenty four h later,
same size EBs from each group was transferred to differ-
entiation media containing cytokines supportive for he-
matopoiesis. Following 15 days the EBs growth was
checked by invert microscope in all groups. According to
the authors’ observations, the expression of siTGF-bR2 had
no effect on EB size and viability as compared to non-
transduced group. Figure 3 shows GFP? colonies and
GFP? EB in these two transduced groups.
Knockdown of TGF-bR2 Can Promote
Hematopoietic Differentiation
To determine the level of gene expression of siTGF-bR2,
6 days post-transduction ESCs in two siTGF-bR2 and
scrambled groups were analyzed by real-time PCR and
then infected ESCs cluster were taken to EB media. TGF-
bR2 mRNA levels of EBs transduced with siTGF-bR2
Lentivirus showed significantly lower levels than the
scrambled group, which can be a consequence of siRNA
activity on gene silencing of TGF-bR2 (0.225313 ±
0.036646) vs. (0.913831 ± 0.007828) (Table 2). Figure 4
shows quantitative real-time PCR confirming the expres-
sion of TGF-bR2 to be reduced in 6 Day post transduction-
ESC.
Fig. 2 A, B HEK-293T cells
transfected with lentiviral
plasmid expressing eGFP after
48 h, C HDFs transducted by
eGFP lentiviruses after 72 h
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Expression Pattern of Globin and Non-globin
Markers of Hematopoietic Progenitor-Like Cells
Expanded from EBs
To determine whether TGF signaling inhibition might
promote hematopoietic progenitor development in EBs, the
authors incubated EBs for 15 days and checked the ex-
pression level of hematopoietic specific genes in days 7 and
15 during EB differentiation. They examined known genes
to be expressed at an early stage of hematopoietic differ-
entiation using Q-RT-PCR. Core pluripotency factors such
as POU5F1 (OCT4) were expectedly down regulated dur-
ing EB formation and hematopoietic differentiation
(15DEB: test vs. control -6.958 ± 0.05919 vs. -1.259 ±
0.08664; p B 0.0310) as shown in Fig. 5A. Furthermore,
they found low expression of mesodermal marker like
Brachyury gene in ESC but it was ascending in EB at
7 days and decreased during EB formation. The expression
of Brachyury in siTGF group as compared with control
group in EB at 7 days was significant (43.94 ±
1.414 vs. 19.82 ± 0.7072; p B 0.0145) but in EB at 15 day
there was no significant difference as compared to the
control group. To characterize potential hematopoietic
cells initially, the authors focused on CD34 and GATA1
known as good markers of very early hematopoietic pre-
cursors derived from hESC [10]. The expression of CD34
and GATA1 genes were increased by partial inhibition of
TGF signaling as compared to control group
(4.7917 ± 0.1328 vs. 1.7715 ± 0.0061 respectively;
p B 0.032 for CD34), (2.6019 ± 0.2069 vs. 0.45061 ±
0.4075 respectively; p B 0.004 for GATA1). Figure 5
shows the expression graph of these markers with the
comparison to GAPDH. The expression pattern of four
globins, epsilon and gamma (as fetal globins) and alpha
and beta (as adult globins) was examined in cultured EB at
days 7 and 15 in all groups as shown in Fig. 6. The present
results determined that during the early stage of EB de-
velopment, the expression level of epsilon and gamma
globins was ascending which has been implicated in up-
regulating embryonic globin synthesis in the human EBs.
Alpha expression was detected slightly on the fifteenth day,
Fig. 3 A ESC colony transduced with scramble, B EB transduced with scramble in day 15, C ESC colony transduced with siTGF-bR2, D EB
transduced with siTGF-bR2 in day 15
Table 2 CT values of GAPDH and TGF-bR2 detected by Q-RT-PCR
Sample GAPDH CT value average TGF-bR2 CT value average 2-DDCt average
scr-siRNA 24.72 ± 0.2200 16.11 ± 0.1450 0.913831 ± 0.007828
TGF-bR2-siRNA 15.20 ± 0.2200 27.78 ± 0.5450 0.225313 ± 0.036646
Fig. 4 The expression level of TGF-bR2 mRNA in EBs that
transduced with siTGF-bR2 Lentivirus as compared to scramble
group
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but the expression of b-globin mRNA was not significantly
altered as compared with HSC.
In the present work, the authors have attempted to clarify
the influence of TGF-b signaling inhibition in the early he-
matopoietic differentiation potential of hEB-derived cells.
For this approach lentiviral expression of siTGF-bR2 was
used. The differentiation technique included EB formation in
combination with cytokines supportive for hematopoiesis.
The selective marker to distinguish transduction efficiency
was the co-expression of GFP by siTGF-bR2. At least 7 and
15 days EB were characterized following differentiation by
focusing on some hematopoietic marker expression such as
CD34,GATA1 and globins by real-time PCR. The significant
outcome of this project was the influence of partial TGF-b
signaling inhibition to promote hematopoietic differentiation.
In the past two decades, scientists have been attempting
to provide a therapeutic alternative to bone marrow trans-
plants for high-risk leukemia and a range of genetic blood
disorders [22]. HSCs derived from human embryonic stem
cells (hESCs) could be appropriate alternative in this goal.
HSCs could give rise to erythroid, myeloid, and lymphoid
lineages but the efficiency of available protocols is low.
For producing the functional HSCs that can reconstitute all
hematopoietic lineages in vivo, it is necessary to under-
stand the regulatory network of genes which interfere on
the differentiation pathway of HSCs and attempt to opti-
mize procedure for differentiation [23].
TGF-b and associated members of the family have diverse
effects on hematopoietic differentiation. These isoforms
(TGF-b1, 2, and 3) have distinct but overlapping effects on
hematopoiesis. Depending on the differentiation stage, TGF
can act as inhibitor or accelerator. Previous studies have
shown the inhibitory effect of TGF-b on early stage of he-
matopoietic differentiation and HSC proliferation.
Many studies have been done to investigate the role of
TGF-b1 (the isotope of TGF-b) in early development of
hemangioblast. These cells are thought to be a bipotent
mesodermal ancestor of endothelial and hematopoietic
cells [24]. TGF-b super-family regulates both stemness and
various cell differentiation pathways among heman-
gioblast. The same molecular profiles and temporal de-
velopmental patterns which have been detected in
endothelial/hematopoietic precursors derived from hEBs
[6, 7, 25]. Poon et al. have examined the effect of TGF-b1
on differentiation of endothelial precursors from ESCs.
They evaluated EB treatment with TGF-b1 on early
Fig. 5 Quantitative real-time
PCR analysis of intracellular
OCT4 (A), Brachyury (B),
CD34 (C), and GATA1
(D) during EB differentiation
reveals distinct changes in cells
expressing siTGF-bR2 in EB
cultured at seventh and fifteenth
days. Expression is shown as
mean ± SEM of three
independent experiments and
calibrate with the gene
expression in undifferentiated
human embryonic stem cells.
Fold change in expression from
undifferentiated hEB cells was
calculated using the ‘‘2-DDCt
method’’ based on the CT for
each target gene and internal
normalizations with GAPDH.
N = 3, significance between
each sample and the control
(group 1) was calculated by
Student’s t test
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differentiation showing that TGF-b1 can deplete the ex-
pression of endothelial precursor marker [12, 15]. In ad-
dition TGF-b1 treatment of day 13 EBs are assessed for
CD34 and GATA2 RNA levels, the two hematopoietic
markers which can be expressed at low levels during early
EB development [25]. Interestingly, EB treated with TGF-
b at early differentiation stage, prevents expression of en-
dothelial and hematopoietic markers [15].
In the adult blood system, TGF-b1 is known to regulate
G1/S cell-cycle progression to maintain a primitive and
undifferentiated population of HSC progenitors [26]. Ad-
ditionally, TGF-b1 inhibits the in vitro HSC proliferation.
Delayed addition of TGF-b1 until the HSC had undergone
three divisions (eight cells/well) was still able to cause
growth arrest of the cells at that stage. Examining the ef-
fects of TGF-b on hematopoietic cell growth in long-term
bone marrow cultures (LTBMCs) has shown the produc-
tion of TGF-b by stromal cells which has a negative-
feedback loop to maintain stem cell quiescence and to in-
hibit progenitor cell cycling [27]. Addition of neutralizing
TGF-b antibodies to hematopoietic cell growth in
LTBMCs resulted in increased output of mature myeloid
cells. The neutralization of TGF-b in hematopoietic stem/
progenitor cells derived from UCB cells in vitro has given
the therapeutic potential to these cells [28]. The same
subsequent experiments have shown that morpholino
antisense nucleotides (MAS) to TGF-b1 or TGF-bRII in-
duce HSC survival, reduce the number of HSC if required
for hematopoietic repopulation, and decrease the time for
engraftment [27]. A direct inhibitory effect of TGF-b1 on
purified CD34 human stem/progenitor cells has also been
reported [29]. Depending on the cell type in the late dif-
ferentiation TGF-b accelerated the dendritic cell differ-
entiation from common dendritic cell progenitors [30].
However, TGF-b repressed development of natural killer
(NK) cells from CD34(?) progenitors, and inhibited dif-
ferentiation of CD16(?) NK cells [31].
Conclusions
According to the information obtained from previous re-
searches about negative regulatory performance of TGF-b
during differentiation, it has been mentioned that TGF-bR2
transcripts could be detected in undifferentiated human
ESCs [12, 15]. In the present study, the TGF regulatory
activities were reduced during differentiation through
knockdown TGF-bR2 expression to promote heman-
gioblast formation. Real-time PCR analysis on the ex-
pression level of hematopoietic-specific genes has shown
2–3-folds increase in EBs after TGF signaling inhibition.
The findings of the present study may confirm the
Fig. 6 Quantitative real-time
PCR analysis of embryonic (e),
fetal (c), and adult (b and a)
globin expression during EB
differentiation. The relative
level of each globin mRNA is
shown as fold value of the level
of each globin mRNA in ESCs.
Results were performed in
triplicate and mRNA levels
were normalized to GAPDH
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assumption that TGF receptor silencing can affect the in-
hibitory role of TGF-b during hematopoietic differ-
entiation. Many questions about the features and the roles
of Smad pathway co-factors in ESCs stemness or differ-
entiation have not completely answered yet [12]. On the
other hand, the transcriptional cascade(s) switched on/off
by Smad-specific signaling pathways is/are still missing in
human ESCs. Therefore, to ensure the present hypothesis,
it is necessary to examine the effects of other sub-family of
TGF-b like Smad2 or Smad7 in Smad pathway.
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